Joseph P Hagan insider trades

Open-market stock purchases and sales by Joseph P Hagan, Chief Executive Officer at Regulus Therapeutics Inc, from SEC Form 4 filings since Jan 22, 2010.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • RGLS Regulus Therapeutics Inc: 5 buys, 17 sales, last Jun 25, 2025
  • AUPH Aurinia Pharmaceuticals Inc: 3 sales, last May 19, 2023
  • ZSAN Zosano Pharma Corp: other filings, last Jun 10, 2021
  • OREX Orexigen Therapeutics, Inc: 1 buy, 9 sales, last Feb 3, 2015

Get free alerts when Joseph P Hagan files a new trade →